Jubilant Biosys is first to add ForteBio's latest SPR System in India, for fragment screening and characterization of lead compounds
Summary
The Pioneer FE system from ForteBio, the Biologics Business Unit of Molecular Devices, represents the next generation SPR instrumentation for label-free characterization of biomolecules. Sensitive enough to measure high affinity and covalent binding events, the Pioneer systems also uses a unique OneStep® gradient injection technology to facilitate fragment screening. Said Marcel Velterop, President of Jubilant Biosys, "The addition of the Pioneer SPR system will significantly upgrade and speed up our small molecule hit-finding engine for novel target classes." Greg Milosevich, President of Molecular Devices, commented, "We are pleased to have Jubilant adopt the Pioneer platform and look forward to supporting them and their customers goals in fast-tracking small molecule drug discovery programs." Jubilant Biosys has demonstrated expertise across multiple therapeutic areas including but not limited to Oncology, Metabolic Disorders, Pain & Inflammation and CNS.
Classifications
AskAI Classifications
LabelsLinked Companies
